JPH0613538B2 - Method for producing phospholipid - Google Patents
Method for producing phospholipidInfo
- Publication number
- JPH0613538B2 JPH0613538B2 JP62015782A JP1578287A JPH0613538B2 JP H0613538 B2 JPH0613538 B2 JP H0613538B2 JP 62015782 A JP62015782 A JP 62015782A JP 1578287 A JP1578287 A JP 1578287A JP H0613538 B2 JPH0613538 B2 JP H0613538B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- phospholipid
- solvent
- chloroform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003904 phospholipids Chemical class 0.000 title claims description 55
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 125000006239 protecting group Chemical group 0.000 claims description 29
- 125000002252 acyl group Chemical group 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 24
- -1 cyclic saturated Chemical class 0.000 claims description 23
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical class OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 11
- 235000012239 silicon dioxide Nutrition 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 238000005947 deacylation reaction Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 230000020176 deacylation Effects 0.000 claims description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 150000003077 polyols Chemical group 0.000 claims description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical group CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 claims description 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical group CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 125000003128 glycerophosphate group Chemical group 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 2
- INAPMGSXUVUWAF-UHFFFAOYSA-L (2,3,4,5,6-pentahydroxycyclohexyl) phosphate Chemical group OC1C(O)C(O)C(OP([O-])([O-])=O)C(O)C1O INAPMGSXUVUWAF-UHFFFAOYSA-L 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 10
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 238000004809 thin layer chromatography Methods 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229940046257 glyceryl phosphate Drugs 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 150000003905 phosphatidylinositols Chemical class 0.000 description 7
- 239000002798 polar solvent Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical class OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 5
- 150000008065 acid anhydrides Chemical class 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- JDQJWBCSXZWVGM-UHFFFAOYSA-N acetonitrile;2-propan-2-yloxypropane Chemical compound CC#N.CC(C)OC(C)C JDQJWBCSXZWVGM-UHFFFAOYSA-N 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- GGQOPZKTDHXXON-UHFFFAOYSA-N hexane;methanol Chemical compound OC.CCCCCC GGQOPZKTDHXXON-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 125000001095 phosphatidyl group Chemical group 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 3
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- FRMZOWIQVCBEAC-UHFFFAOYSA-N glycerylphosphorylethanolamine Chemical compound OCCN(P(O)(O)=O)CC(O)CO FRMZOWIQVCBEAC-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000008348 synthetic phosphatidyl choline Substances 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- RLCKHJSFHOZMDR-UHFFFAOYSA-N (3R, 7R, 11R)-1-Phytanoid acid Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-UHFFFAOYSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- YNCPXBIZAPNQIJ-UHFFFAOYSA-N 1h-imidazole;sodium Chemical compound [Na].C1=CNC=N1 YNCPXBIZAPNQIJ-UHFFFAOYSA-N 0.000 description 2
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 2
- NEZDNQCXEZDCBI-UHFFFAOYSA-N 2-azaniumylethyl 2,3-di(tetradecanoyloxy)propyl phosphate Chemical compound CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCC NEZDNQCXEZDCBI-UHFFFAOYSA-N 0.000 description 2
- RLCKHJSFHOZMDR-PWCSWUJKSA-N 3,7R,11R,15-tetramethyl-hexadecanoic acid Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-PWCSWUJKSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 description 2
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002032 methanolic fraction Substances 0.000 description 2
- 229940042880 natural phospholipid Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- TVUUVVWHDOVWKJ-UHFFFAOYSA-N propan-2-one;2,2,4-trimethylpentane Chemical compound CC(C)=O.CC(C)CC(C)(C)C TVUUVVWHDOVWKJ-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 238000006257 total synthesis reaction Methods 0.000 description 2
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- HEVMDQBCAHEHDY-UHFFFAOYSA-N (Dimethoxymethyl)benzene Chemical compound COC(OC)C1=CC=CC=C1 HEVMDQBCAHEHDY-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 1
- BGYPHYAFWDUNDD-UHFFFAOYSA-N 1h-benzimidazole;sodium Chemical compound [Na].C1=CC=C2NC=NC2=C1 BGYPHYAFWDUNDD-UHFFFAOYSA-N 0.000 description 1
- HXVNBWAKAOHACI-UHFFFAOYSA-N 2,4-dimethyl-3-pentanone Chemical compound CC(C)C(=O)C(C)C HXVNBWAKAOHACI-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- HLLSOEKIMZEGFV-UHFFFAOYSA-N 4-(dibutylsulfamoyl)benzoic acid Chemical compound CCCCN(CCCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 HLLSOEKIMZEGFV-UHFFFAOYSA-N 0.000 description 1
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- SFGGITYAMFZATC-UHFFFAOYSA-N ClC(Cl)Cl.CC(C)CC(C)(C)C Chemical compound ClC(Cl)Cl.CC(C)CC(C)(C)C SFGGITYAMFZATC-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- KYLYEZUDQSQIRP-UHFFFAOYSA-N D,L-(alpha-Glyceryl)-2-(dimethylammonium)-aethylphosphat Natural products CN(C)CCOP(O)(=O)OCC(O)CO KYLYEZUDQSQIRP-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- VAPZPBBPRKQWNR-AKGZTFGVSA-N OCC(O)CP(=O)=N[C@@H](CO)C(O)=O Chemical compound OCC(O)CP(=O)=N[C@@H](CO)C(O)=O VAPZPBBPRKQWNR-AKGZTFGVSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical group OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 1
- LYBDVVBIMGTZMB-HVIJGSDCSA-N [3-[hydroxy-[(2s,3r,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-tetradecanoyloxypropyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COP(O)(=O)OC1[C@@H](O)[C@@H](O)C(O)[C@@H](O)[C@@H]1O LYBDVVBIMGTZMB-HVIJGSDCSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- UWQIEDGNGUIPKS-UHFFFAOYSA-N benzene 2,2,4-trimethylpentane Chemical compound C1=CC=CC=C1.CC(C)CC(C)(C)C UWQIEDGNGUIPKS-UHFFFAOYSA-N 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- AQHMSOCWYFWQRO-UHFFFAOYSA-N benzene;methylsulfinylmethane Chemical compound CS(C)=O.C1=CC=CC=C1 AQHMSOCWYFWQRO-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- AHAREKHAZNPPMI-UHFFFAOYSA-N hexa-1,3-diene Chemical compound CCC=CC=C AHAREKHAZNPPMI-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- HUAZGNHGCJGYNP-UHFFFAOYSA-N propyl butyrate Chemical compound CCCOC(=O)CCC HUAZGNHGCJGYNP-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- LPWCRLGKYWVLHQ-UHFFFAOYSA-N tetradecanoyl chloride Chemical compound CCCCCCCCCCCCCC(Cl)=O LPWCRLGKYWVLHQ-UHFFFAOYSA-N 0.000 description 1
- 238000005708 tetrahydropyranylation reaction Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明はリン脂質混合物を原料として、構造の明確なリ
ン脂質を製造する方法に関するものである。TECHNICAL FIELD The present invention relates to a method for producing a phospholipid having a definite structure from a phospholipid mixture as a raw material.
リン脂質は単に乳化剤に用い得るのみならず、リボソー
ムの基材として薬剤運搬体、人工血液、人工細胞等への
応用が近年注目されており、またそれ自体生理活性、薬
理作用を持つものとして、医学、薬学、工学的分野等に
おいて様々な用途が考えられている。このような多様な
要求に対応するためには、それぞれの用途に応じた構造
を有するリン脂質を効率的に製造することが必要とな
る。Phospholipids can be used not only as emulsifiers, but in recent years, application to drug carriers, artificial blood, artificial cells, etc., as a base material for ribosomes has attracted attention in recent years. Various applications have been considered in the fields of medicine, pharmacy, engineering and so on. In order to meet such various demands, it is necessary to efficiently produce phospholipids having a structure according to each application.
従来構造の明確なリン脂質を製造する方法としては、全
合成により製造する方法、グリセリルリン酸エステルを
原料としてアシル基導入により製造する方法、既に構造
の明確な合成リン脂質を原料として塩基部分の交換によ
り別の構造に変換する方法などが知られている。As a method for producing a phospholipid having a well-defined structure, a method for producing by total synthesis, a method for producing an acyl group by using a glyceryl phosphate as a raw material, and a synthetic phospholipid having a well-defined structure as a raw material for forming a base moiety A method of converting to another structure by exchange is known.
しかしながら、上記全合成により製造する方法はホスフ
ァチジルコリンなどで知られているが、工程が長く複雑
で大規模化が困難、副生する異性体等の分離が困難など
の欠点があり、製造し得るリン脂質の種類も限られてい
る。However, the method for producing by the above-mentioned total synthesis is known for phosphatidylcholine and the like, but it has drawbacks such as long process, complicated and difficult to scale up, and separation of by-product isomers. The types of lipids are also limited.
リン脂質を脱アシルしたグリセリルリン酸エステルを原
料としてアシル基導入により製造する方法は、含窒素ア
ルコール残基またはポリオール残基部分(以下、塩基と
呼ぶ)の種類によっては、アシル化反応時にグリセリン
部分の他にもアシル基が導入されてしまうため、この方
法では製造することができない。Depending on the type of nitrogen-containing alcohol residue or polyol residue part (hereinafter referred to as a base), a method for producing an acyl group by using a glyceryl phosphate ester obtained by deacylating a phospholipid as a raw material is a glycerin part during the acylation reaction. In addition to the above, an acyl group is introduced, so that it cannot be produced by this method.
またホスファチジルコリンの場合に限れば、ホスファチ
ジルコリンを含む粗リン脂質の脱アシル化からグリセリ
ルホスホリルコリンをカドミウムをはじめとする重金属
との錯塩として分離し、アシル基を導入することにより
合成ホスファチジルコリンを製造する方法が知られてい
るが、微量に残存する重金属の除去が困難であり、製造
したホスファチジルコリンの用途が限定されてしまう。Also, only in the case of phosphatidylcholine, there is known a method for producing synthetic phosphatidylcholine by separating glycerylphosphorylcholine as a complex salt with heavy metals such as cadmium from deacylation of crude phospholipid containing phosphatidylcholine, and introducing an acyl group. However, it is difficult to remove the heavy metal remaining in a trace amount, and the use of the produced phosphatidylcholine is limited.
さらに既に構造の明確な合成リン脂質を原料として塩基
部分の交換により別の構造に変換する方法は、合成ホス
ファチジルコリンを原料としてホスフォリパーゼDを作
用させることによりホスファチジルエタノールアミン、
ホスファチジルグリセロールに変換する場合などが知ら
れている。しかし、一旦ホスファチジルコリンを合成し
た上で変換しなければならず、変換時にロスが生じるた
め効率が低い。Furthermore, a method of converting a synthetic phospholipid having a well-defined structure as a raw material into another structure by exchanging a base moiety is as follows: phosphatidylethanolamine is produced by reacting phospholipase D with synthetic phosphatidylcholine as a raw material.
It is known to convert to phosphatidylglycerol. However, phosphatidylcholine has to be synthesized first and then converted, and loss occurs during conversion, resulting in low efficiency.
本発明は上記問題点を解決するためのもので、粗リン脂
質を原料とし、簡単な工程で効率よく、構造の明確なリ
ン脂質を製造できるリン脂質の製造方法を提案すること
を目的としている。The present invention is intended to solve the above problems, and an object thereof is to propose a method for producing a phospholipid, which is a crude phospholipid as a raw material and which can efficiently produce a phospholipid having a well-defined structure in a simple process. .
本発明は、粗リン脂質に着脱可能な保護基を導入し、脱
アシル化して下記式(I) (式中、Xは含窒素アルコール残基またはポリオール残
基を、Yは容易に着脱可能な保護基を、nは12以下の
自然数を示す。) で示されるグリセリルリン酸エステル誘導体に変換し、
ケイ酸を分離剤として分離精製した後、任意のアシル基
を導入して保護基を脱離させることを特徴とするリン脂
質の製造方法である。The present invention introduces a removable protecting group into a crude phospholipid and deacylates it to the following formula (I) (In the formula, X represents a nitrogen-containing alcohol residue or a polyol residue, Y represents an easily removable protecting group, and n represents a natural number of 12 or less.), And a glyceryl phosphate derivative represented by
A method for producing a phospholipid, which comprises separating and purifying silicic acid as a separating agent, and then introducing an arbitrary acyl group to remove the protecting group.
本発明では、粗リン脂質の塩基に適当な保護基(置換
基)を導入した後、脱アシル化してグリセリルリン酸エ
ステル誘導体とし、ケイ酸クロマトグラフィーで分離精
製する。そして各グリセリルリン酸エステル誘導体にア
シル基を導入してリン脂質誘導体とし、保護基を脱離さ
せてリン脂質を製造する。In the present invention, a suitable protecting group (substituent) is introduced into the base of the crude phospholipid, followed by deacylation to give a glyceryl phosphate derivative, which is separated and purified by silicic acid chromatography. Then, an acyl group is introduced into each glyceryl phosphate derivative to form a phospholipid derivative, and the protecting group is eliminated to produce a phospholipid.
本発明において重要な点は、リン脂質をグリセリルリン
酸エステル誘導体として分離精製することである。リン
脂質の脱アシル化物であるグリセリルリン酸エステルは
溶解性等の問題から、その混合物を工業的に分離精製す
る方法が存在しなかった。本発明においては、保護基を
導入してグリセリルリン酸エステル誘導体とすることに
より、ケイ酸クロマトグラフィーによる分離精製が可能
である。この場合塩基の種類により保護基の導入数が変
わるため、リン脂質の形でのケイ酸クロマトグラフィー
よりも分離精製能が向上する。保護基はまたグリセリル
リン酸エステル誘導体のグリセリン部分の水酸基に任意
のアシル基を導入してリン脂質誘導体にする際に、塩基
にアシル基が導入されないように保護する役割をも果
す。An important point in the present invention is to separate and purify phospholipid as a glyceryl phosphate derivative. Glyceryl phosphate, which is a deacylated phospholipid, has no method for industrially separating and purifying the mixture because of problems such as solubility. In the present invention, by introducing a protecting group into a glyceryl phosphate derivative, separation and purification by silicic acid chromatography is possible. In this case, since the number of the protective groups introduced varies depending on the type of base, the separation and purification ability is improved as compared with silicic acid chromatography in the form of phospholipid. The protecting group also plays a role of protecting an acyl group from being introduced into a base when introducing an arbitrary acyl group into the hydroxyl group of the glycerin moiety of the glyceryl phosphate derivative to form a phospholipid derivative.
本発明において用いられる原料粗リン脂質としては、天
然から抽出したあるいは市販のホスファチジルセリン、
ホスファチジルエタノールアミン、ホスファチジルN−
メチルエタノールアミン、ホスファチジルN,N-ジメチル
エタノールアミン、ホスファチジルN,N,N-トリメチルエ
タノールアミン、ホスファチジルグリセロール、ホスフ
ァチジルアミノアシルグリセロール、ホスファチジルグ
リセロリン酸、カルジオリピン、ホスファチジルイノシ
トール、ホスファチジルイノシトールジリン酸、ホスフ
ァチジルイノシトールトリリン酸、糖リン脂質等の混合
物である粗リン脂質を精製することなく、そのまま使用
するとができる。このような粗リン脂質の例としては、
卵黄レシチン、脱脂大豆レシチン、酵母から抽出したリ
ン脂質画分、牛脳から抽出した粗セファリン画分等があ
げられる。粗リン脂質を溶媒分画等により前処理して用
いたり、クロマトグラフィー等により精製して用いるこ
ともできるが、粗リン脂質を精製することなくそのまま
用いる方が工業的に有利である。Raw crude phospholipids used in the present invention include phosphatidylserine extracted from nature or commercially available,
Phosphatidyl ethanolamine, phosphatidyl N-
Methyl ethanol amine, phosphatidyl N, N-dimethyl ethanol amine, phosphatidyl N, N, N-trimethyl ethanol amine, phosphatidyl glycerol, phosphatidyl aminoacyl glycerol, phosphatidyl glycerophosphate, cardiolipin, phosphatidyl inositol, phosphatidyl inositol diphosphate, phosphatidyl inositol triphosphate, The crude phospholipid, which is a mixture of sugar phospholipids, can be used as it is without purification. Examples of such crude phospholipids include:
Examples include egg yolk lecithin, defatted soybean lecithin, phospholipid fraction extracted from yeast, crude cephalin fraction extracted from bovine brain, and the like. The crude phospholipid can be used after being pretreated by solvent fractionation or the like or purified by chromatography or the like, but it is industrially advantageous to use the crude phospholipid as it is without purification.
ホスファチジルコリンは保護基が導入されないため、そ
のままグリセリルホリルコリンを経て合成ホスファチジ
ルコリンを得ることができる。Since a protecting group is not introduced into phosphatidylcholine, synthetic phosphatidylcholine can be obtained through glycerylfolylcholine as it is.
容易に着脱できる保護基は式(I)においてYで示される
基であり、その例としては、直鎖状、分岐鎖状または環
状のアルキル基、直鎖状、分岐鎖状または環状のアルキ
ロイル基、直鎖状、分岐鎖状または環状のアルケニル
基、直鎖状、分岐鎖状または環状のアルケロイル基、お
よびアリール基から選ばれる基を用いることができる。
このような保護基の例としては、粗リン脂質の塩基部分
と結合してアルキルエーテル、アリルエーテル、ベンジ
ルエーテル、トリアリールメチルエーテル、トリアルキ
ルシリルエーテル、テトラヒドロピラニルエーテル等の
エーテル類;酢酸エステル、蟻酸エステル、トリフルオ
ロ酢酸エステル、安息香酸エステル等のエステル類;メ
チレンアセタール、エチリデンアセタール、ベンジリデ
ンアセタール、イソプロピリデンアセタール等のアセタ
ール類などを生成する基をあげることができる。これら
の基の選択については、導入先であるリン脂質の塩基の
官能基の反応性などにより決定することが望ましく、そ
の反応方法および反応条件等については、糖およびアミ
ノ酸の反応に一般に採用されている方法および条件を採
用することができる。ただし、その後の任意のアシル基
導入の反応時に保護基が脱離しないものでなければなら
ない。The easily removable protective group is a group represented by Y in the formula (I), and examples thereof include a linear, branched or cyclic alkyl group, a linear, branched or cyclic alkyloyl group. A group selected from a straight-chain, branched-chain or cyclic alkenyl group, a straight-chain, branched-chain or cyclic alkeroyl group, and an aryl group can be used.
Examples of such protecting groups include ethers such as alkyl ether, allyl ether, benzyl ether, triarylmethyl ether, trialkylsilyl ether, tetrahydropyranyl ether which are bonded to the base moiety of the crude phospholipid; acetic acid ester, Examples thereof include groups that form esters such as formic acid esters, trifluoroacetic acid esters, and benzoic acid esters; acetals such as methylene acetal, ethylidene acetal, benzylidene acetal, and isopropylidene acetal. The selection of these groups is preferably determined by the reactivity of the functional group of the base of the phospholipid to be introduced, and the reaction method and reaction conditions are generally adopted for the reaction of sugars and amino acids. The method and conditions that are present can be adopted. However, the protective group must not be removed during the subsequent reaction of introducing any acyl group.
保護基の導入方法は、例えばベンジル化の場合は、溶媒
としてジメチルスルホキサイド、N,N-ジメチルホルムア
ミド、テトラヒドロフラン、ジオキサン等のよく脱水し
たものを使用し、水素化ナトリウムや金属ナトリウム等
を用いてアルカリ金属のアルコラートを形成させ、続い
てハロゲン化ベンジルを加えることにより、ベンジルエ
ーテルを形成し、水酸基をベンジル基で保護することが
できる。またテトラヒドロピラニール化の場合は、溶媒
としてジクロロメタン、クロロホルム、四塩化炭素、ベ
ンゼン等のリン脂質をよく溶解または分散するものを使
用し、触媒として酢酸、p−トルエンスルホン酸、メタ
ンスルホン酸、H+型イオン交換樹脂等の酸を使用し、3,
4-ジヒドロ−α−ピランと攪拌下に反応させることによ
り、テトラヒドロピラニールエーテルを形成し、水酸基
を保護することができる。他の反応も上記に準じて行う
ことができる。反応温度は保護基の種類により−20〜10
0℃の範囲が適当であるが、基質の安定性から−20〜40
℃が最も好ましい。反応時間は15分〜数日間の範囲で適
宜選択することができる。The method of introducing the protecting group is, for example, in the case of benzylation, dimethyl sulfoxide, N, N-dimethylformamide, tetrahydrofuran, dioxane, or the like, which is well dehydrated, is used, and sodium hydride or sodium metal is used. The benzyl ether can be formed by the formation of an alkali metal alcoholate followed by the addition of a benzyl halide to protect the hydroxyl group with a benzyl group. In the case of tetrahydropyranylation, a solvent that dissolves or disperses phospholipids such as dichloromethane, chloroform, carbon tetrachloride, and benzene is used as a solvent, and acetic acid, p-toluenesulfonic acid, methanesulfonic acid, H Using an acid such as + type ion exchange resin, 3,
By reacting with 4-dihydro-α-pyran under stirring, tetrahydropyranyl ether can be formed and the hydroxyl group can be protected. Other reactions can also be performed according to the above. The reaction temperature is -20 to 10 depending on the type of protecting group.
A range of 0 ° C is suitable, but -20 to 40 due to the stability of the substrate.
C is most preferred. The reaction time can be appropriately selected within the range of 15 minutes to several days.
原料粗リン脂質にYで示される保護基を導入した後、脱
アシル化することにより式(I)で示されるグリセリルリ
ン酸エステル誘導体の混合物を得ることができる。脱ア
シン化の方法は、リン脂質の脱アシル化に一般に用いら
れているメチルエステル化分解あるいはケン化分解等を
採用することができる。A mixture of the glyceryl phosphate derivative represented by the formula (I) can be obtained by introducing a protecting group represented by Y into the raw crude phospholipid and then deacylating. As the method for deacinating, methyl esterification decomposition or saponification decomposition generally used for deacylation of phospholipids can be adopted.
この場合、水酸基を保護したリン脂質の脱アシル化はテ
トラブチルアンモニウムヒドロキサイド等の四級アルキ
ルアンモニウム水酸化物あるいはアルカリ金属などを使
用してアルコリシスすることにより行うことができる
が、低濃度のアルカリ等で穏やかに加水分解してもよ
い。脱アシル化反応に使用する溶媒としてはクロロホル
ム、ジクロロメタン、四塩化炭素、エーテル等がある
が、必要に応じてメタノール、エタノール等の親水性溶
媒との混合溶媒を使用することもできる。反応温度は0
〜100℃の範囲が好ましいが、基質の安定性から0〜40
℃が特に好ましい。反応時間は15〜数日間の範囲で適当
な時間を選択すればよい。In this case, deacylation of the phospholipid with a protected hydroxyl group can be carried out by alcoholysis using a quaternary alkylammonium hydroxide such as tetrabutylammonium hydroxide or an alkali metal, but a low concentration of alkali Etc. to gently hydrolyze. Examples of the solvent used in the deacylation reaction include chloroform, dichloromethane, carbon tetrachloride, ether and the like, but if necessary, a mixed solvent with a hydrophilic solvent such as methanol and ethanol can also be used. Reaction temperature is 0
The range of ~ 100 ° C is preferred, but 0 ~ 40 due to the stability of the substrate.
C is especially preferred. A suitable reaction time may be selected within the range of 15 to several days.
こうして得られた式(I)のグリセリルリン酸エステル誘
導体は原料粗リン脂質の種類により、Xがセリン基、エ
タノールアミン基、N−メチルエタノールアミン基、N,
N-ジメチルエタノールアミン基、N,N,N-トリメチルエタ
ノールアミン基、グリセロール基、アミノアシルグリセ
ロール基、グリセロリン酸基、グリセリルホスファチジ
ル基、イノシトール基、イノシトールリン酸基、イノシ
トールジリン酸基、単糖、二糖またはオリゴ糖の混合物
となっている。そしてこのグリセリルリン酸エステル誘
導体は保護基Yの導入により、全体の極性が低下して有
機溶媒に可溶となり、従来グリセリルリン酸エステルで
は不可能であった液体クロマトグラフィーによる分離精
製が可能となる。また脱アシル化時に生じた脂肪酸、未
反応物等もグリセリルリン酸エステル誘導体混合物と分
離することができる。エステル結合以外のエーテル結
合、酸アミド結合等によるアルキル鎖を持つリン脂質
等、例えばプラズマローゲン類、スフィンゴリン脂質等
もリン脂質のままでは分離が困難であるが、Yの導入に
より極性が極めて低くなるために容易に分離することが
できる。In the glyceryl phosphate derivative of formula (I) thus obtained, X is a serine group, ethanolamine group, N-methylethanolamine group, N,
N-dimethylethanolamine group, N, N, N-trimethylethanolamine group, glycerol group, aminoacylglycerol group, glycerophosphate group, glycerylphosphatidyl group, inositol group, inositol phosphate group, inositol diphosphate group, monosaccharide, disaccharide It is a mixture of sugars or oligosaccharides. The introduction of the protective group Y in this glyceryl phosphate derivative reduces the overall polarity and makes it soluble in an organic solvent, which enables separation and purification by liquid chromatography, which was impossible with conventional glyceryl phosphate. . In addition, fatty acids generated during deacylation, unreacted substances and the like can also be separated from the glyceryl phosphate derivative mixture. Phospholipids having alkyl chains such as ether bonds other than ester bonds and acid amide bonds, such as plasmalogens and sphingolipids, are difficult to separate with phospholipids, but the introduction of Y has extremely low polarity. Therefore, it can be easily separated.
分離剤として使用するケイ酸としては、破砕型のもので
もゲル状のもの(シリカゲル等)でもよく、粒径10〜80
0μm、細孔径0.25〜10μmの範囲のものが好ましい。
市販品を用いることもでき、例えば、Clarkson Chemica
ls Co.製Unisil、和光純薬工業(株)製ワコーゲル、Me
rck社製Silica Gel60、(株)ヤトロン製イアトロビー
ズ(いずれも商標)等が分離性能等の面で好適である。
高速液体クロマトグラフィー用といて市販されているケ
イ酸は、分離性能では一段優れてはいるが、コスト的に
は不利である。その他の製品でも、使用前に粒径を揃え
る等の精製を充分に行えば、使用に耐える。The silicic acid used as a separating agent may be a crushed type or a gel type (silica gel, etc.) and has a particle size of 10-80.
Those having a diameter of 0 μm and a pore diameter of 0.25 to 10 μm are preferable.
Commercial products can also be used, for example Clarkson Chemica
Unisil manufactured by ls Co., Wakogel manufactured by Wako Pure Chemical Industries, Ltd., Me
Silica Gel 60 manufactured by rck, iatro beads manufactured by Yatron Co., Ltd. (both are trademarks), and the like are preferable in terms of separation performance and the like.
Although silicic acid, which is commercially available for high performance liquid chromatography, is more excellent in separation performance, it is disadvantageous in cost. Other products can be used if they are sufficiently refined such that the particle size is made uniform before use.
分離の方法としては、上述のケイ酸を使用する公知のカ
ラムクロマトグラフィーに準じた方式を採用することが
できる。すなわちグリセリルリン酸エステル誘導体が吸
着し得る低極性溶媒でケイ酸を前処理し、同様の低極性
溶媒に溶かしたグリセリルリン酸エステル誘導体を含む
試料を加えてケイ酸に展着させ、不用物等を洗い流した
後、高極性の溶媒を用いてグリセリルリン酸エステル誘
導体を順次溶離させる。吸着剤から不用物を洗い流す洗
浄効果を高めるためには、化合物が溶離しない程度に極
性の高い溶媒を用いることが望ましい。グリセリルリン
酸エステル誘導体をXの種類ごとに順次溶離させるため
には、高極性溶媒を少しずつより極性の高いものに切り
替えながら順次流す、傾斜溶出を行うなどの操作が望ま
しい。As a method of separation, a method based on a known column chromatography using the above-mentioned silicic acid can be adopted. That is, silicic acid is pretreated with a low-polarity solvent capable of adsorbing a glyceryl phosphate ester derivative, and a sample containing a glyceryl phosphate ester derivative dissolved in a similar low-polarity solvent is added to spread it onto silicic acid to dispose of it. After washing off, the glyceryl phosphate derivative is sequentially eluted with a highly polar solvent. In order to enhance the cleaning effect of washing away the unnecessary substances from the adsorbent, it is desirable to use a solvent having a high polarity so that the compound does not elute. In order to sequentially elute the glyceryl phosphate ester derivative for each type of X, it is desirable to perform operations such as sequentially flowing the highly polar solvent while gradually switching to a more polar solvent, and performing gradient elution.
このような溶媒系としては、例えば以下のような組み合
せを示すことができる。高極性溶媒としては、炭素数1
〜10の直鎖状、分岐鎖状もしくは環状の脂肪族アルコー
ルまたはアルデヒド等および水もしくはそれらの混合物
などがあり、これらは分子内にエーテル結合、エステル
結合または二重結合を有していてもよく、アルキル基、
シアン基、アミン基等の官能基を有していてもよい。こ
のような高極溶媒の例としてはメタノール、3%含水イ
ソプロパノール、アセトニトリル、酪酸プロピルおよび
これらのうち2種以上の混合系があげられる。低極性溶
媒としては、炭素数1〜10の直鎖状、分岐鎖状もしくは
環状の炭化水素化合物または炭素数1〜2のハロゲン化
炭化水素化合物等があり、これらは分子内に二重結合ま
たはエーテル結合を有していてもよく、アルキル基等の
官能基を有していてもよい。またこれらと上記高極性溶
媒群から選ばれる少なくとも1種以上の混合物も使用可
能である。このような低極性溶媒の例としてはn−ヘキ
サン、イソオクタン、ジエチルエーテル、ジイソプロピ
ルエーテル、シクロヘキサン、ベンゼン、キシレン、ク
ロロホルム、四塩化炭素、ジクロロエタン、イソオクタ
ン−クロロホルム(3:7)、n−ヘキサン−ベンゼン
(4:7)、クロロホルム−メタノール−水(65:25:4)
等があげられる。As such a solvent system, for example, the following combinations can be shown. Highly polar solvent has 1 carbon
~ 10 linear, branched or cyclic aliphatic alcohols or aldehydes and the like and water or a mixture thereof and the like, which may have an ether bond, an ester bond or a double bond in the molecule. , An alkyl group,
It may have a functional group such as a cyan group or an amine group. Examples of such a high polar solvent include methanol, 3% hydrous isopropanol, acetonitrile, propyl butyrate, and a mixed system of two or more of these. The low-polarity solvent includes a linear, branched or cyclic hydrocarbon compound having 1 to 10 carbon atoms or a halogenated hydrocarbon compound having 1 to 2 carbon atoms. It may have an ether bond, or may have a functional group such as an alkyl group. Further, a mixture of these and at least one kind selected from the above-mentioned highly polar solvent group can also be used. Examples of such low polar solvents include n-hexane, isooctane, diethyl ether, diisopropyl ether, cyclohexane, benzene, xylene, chloroform, carbon tetrachloride, dichloroethane, isooctane-chloroform (3: 7), n-hexane-benzene. (4: 7), chloroform-methanol-water (65: 25: 4)
Etc.
このようにして分離、精製したグリセリルリン酸エステ
ル誘導体は、任意のアシル基を導入することにより、リ
ン脂質誘導体にすることができる。アシル基の導入方法
としては、脂肪酸塩化物による方法、酸無水物による方
法、酸イミダゾール塩による方法など、任意の方法を採
用することができるが、不飽和脂肪酸を導入しようとす
る場合は酸無水物による方法が安全である。The glyceryl phosphate derivative thus separated and purified can be made into a phospholipid derivative by introducing an arbitrary acyl group. As the method for introducing an acyl group, any method such as a method using a fatty acid chloride, a method using an acid anhydride, or a method using an acid imidazole salt can be adopted, but when an unsaturated fatty acid is to be introduced, an acid anhydride is used. The thing method is safe.
導入する任意の脂肪酸としては、炭素数30以下の直鎖
状、分岐鎖状の飽和または不飽和脂肪酸を用いることが
でき、例としては、酢酸、酪酸、カプリル酸、ラウリン
酸、ステアリン酸、セロチン酸、パルミトレイン酸、エ
ライジン酸、エルカ酸、ネルボン酸、リノール酸、αー
シノレン酸、γ−リノレン酸、アラキドン酸、ドコサヘ
キサエン酸、イソステアリン酸、フィタン酸などをあげ
ることができる。原理的にはこれ以外のものでも導入す
るとが可能である。これらのカルボン酸を目的に応じ、
単独あるいは自由に組み合わせて用いることができる。As the arbitrary fatty acid to be introduced, a linear or branched saturated or unsaturated fatty acid having a carbon number of 30 or less can be used, and examples thereof include acetic acid, butyric acid, caprylic acid, lauric acid, stearic acid, and serotonin. Examples thereof include acids, palmitoleic acid, elaidic acid, erucic acid, nervonic acid, linoleic acid, α-cinolenic acid, γ-linolenic acid, arachidonic acid, docosahexaenoic acid, isostearic acid and phytanic acid. In principle, it is possible to introduce other than this. Depending on the purpose of these carboxylic acids,
They can be used alone or in any combination.
アシル基を導入する反応方法は、例えば上記カルボン酸
を酸無水物、酸ハロゲン化物、脂肪酸イミダゾール化物
等の活性アシル化状態にしたものをアシル化剤とし、水
酸基を保護した式(I)のグリセリルリン酸エステル誘導
体のグリセリル部分の水酸基と反応させる。アシル化剤
の添加量は反応基質に対し1〜20当量、好ましくは1〜
5当量とするのが良い。The reaction method for introducing an acyl group is, for example, an acid anhydride, an acid halide, or a fatty acid imidazole compound which is in an active acylation state as an acylating agent, and a hydroxyl group-protected glyceryl compound of formula (I). React with the hydroxyl group of the glyceryl moiety of the phosphate derivative. The amount of the acylating agent added is 1 to 20 equivalents, preferably 1 to the reaction substrate.
5 equivalents is good.
反応に使用する触媒は塩基性触媒が用いられ、好ましく
はリン脂質の異性化を生じさせない穏やかなものがよ
い。アシル化剤に酸無水物、酸ハロゲン化物を使用する
場合、触媒としては、ピリジン、N,N-−ジメチル−4−
アミノピリジン、N,N-−ジメチル−4−アミノ−2−メ
チルピリジン、4−ピロリジノピロリジン等のピリジン
誘導体、およびトリエチルアミン、トリブチルアミン等
の三級アミン類等が使用できるが、酸無水物の場合には
N,N-ジメチル−4−アミンピリジンまたは4−ピロリジ
ノピリジン、酸ハロゲン化物の場合にはピリジンが好ま
しい。脂肪酸イミダゾール化物を使用する場合はイミダ
ゾールナトリウム、トリアゾールナトリウム、ベンツイ
ミダゾールナトリウムなどの含窒素五員複素環状化合物
のアルカリ塩が使用できるが、なかでもイミダゾールナ
トリウムが好ましい。触媒の添加量は原料に対し0.01〜
20当量程度、好ましくは0.1〜2当量が良い。The catalyst used in the reaction is a basic catalyst, preferably a mild one that does not cause isomerization of phospholipids. When an acid anhydride or acid halide is used as the acylating agent, the catalyst may be pyridine or N, N-dimethyl-4-
Pyridine derivatives such as aminopyridine, N, N-dimethyl-4-amino-2-methylpyridine and 4-pyrrolidinopyrrolidine, and tertiary amines such as triethylamine and tributylamine can be used, but acid anhydrides in case of
N, N-Dimethyl-4-aminepyridine or 4-pyrrolidinopyridine, preferably pyridine in the case of an acid halide. When a fatty acid imidazole compound is used, an alkali salt of a nitrogen-containing five-membered heterocyclic compound such as imidazole sodium, triazole sodium, and benzimidazole sodium can be used, but imidazole sodium is preferable. The amount of catalyst added is 0.01 to the raw material
About 20 equivalents, preferably 0.1 to 2 equivalents are good.
溶媒としてはクロロホルム、ジクロロメタン、四塩化炭
素等のハロゲン化炭化水素、ベンゼン、トルエン等の芳
香族炭化水素、ヘキサン、ヘプタン等の炭化水素;酢酸
エチル、酢酸プロピル等のエステル;ジエチルエーテ
ル、テトラヒドロフラン等のエーテル類などを用いるこ
とができ、これらの溶媒は乾燥していることが好まし
い。Examples of the solvent include halogenated hydrocarbons such as chloroform, dichloromethane and carbon tetrachloride, aromatic hydrocarbons such as benzene and toluene, hydrocarbons such as hexane and heptane; esters such as ethyl acetate and propyl acetate; diethyl ether, tetrahydrofuran and the like. Ethers and the like can be used, and these solvents are preferably dried.
アシル化反応は0〜80℃程度、好ましくは10〜50℃の範
囲で行うことができ、通常15分〜数日間、好ましくは30
分〜3日間で終了し、目的とする任意のアシル基で組み
換えたリン脂質誘導体を得ることができる。また反応系
は必ずしも制限されないが、特にアシル基に高度不飽和
脂肪酸を用いる場合は、窒素、アルゴン等の不活性ガス
気流下で行うことが好ましい。The acylation reaction can be carried out in the range of about 0 to 80 ° C, preferably 10 to 50 ° C, usually 15 minutes to several days, preferably 30 minutes.
After a lapse of from 3 minutes to 3 days, a desired phospholipid derivative having a desired acyl group can be obtained. The reaction system is not necessarily limited, but when a highly unsaturated fatty acid is used for the acyl group, it is preferably carried out under a stream of an inert gas such as nitrogen or argon.
上記のようにして任意のアシル基の導入により得たリン
脂質誘導体の保護基を脱離させることにより、構造の明
確なリン脂質を得ることができる。保護基を離脱させる
方法としては、酸触媒による加水分解、還元反応などの
通常保護基の結合を切断するために用いられている方法
を採用することができる。ただし、アルカリ条件下では
アシル基の脱離をも生じる可能性があるため、避けるこ
とが望ましい。還元により脱離する保護基を使用した場
合、反応は水素による接触還元が一般的であるが、もっ
と穏やかなギ酸、ギ酸アンモニウム、シクロヘキサジエ
ン等を水素供給源とした還元反応を用いることができ
る。By removing the protective group of the phospholipid derivative obtained by introducing an arbitrary acyl group as described above, a phospholipid having a definite structure can be obtained. As a method for removing the protecting group, a method usually used for breaking the bond of the protecting group, such as hydrolysis with an acid catalyst and reduction reaction, can be adopted. However, under alkaline conditions, elimination of the acyl group may occur, so it is desirable to avoid it. When a protecting group that is eliminated by reduction is used, the reaction is generally catalytic reduction with hydrogen, but a milder reduction reaction using formic acid, ammonium formate, cyclohexadiene, or the like as a hydrogen source can be used.
溶媒としては、ジクロロメタン、クロロホルム等のハロ
ゲン化炭化水素類;テトラヒドロフラン、ジエチルエー
テル等のエーテル類;ベンゼン、トルエン等の芳香族炭
化水素類を使用することができ、触媒にはパラジウム、
酸化パラジウム、パラジウム−カーボン等を用いること
ができる。触媒添加量は、保護基1モルにつき10〜100g
のパラジウム量が好ましい。As the solvent, halogenated hydrocarbons such as dichloromethane and chloroform; ethers such as tetrahydrofuran and diethyl ether; aromatic hydrocarbons such as benzene and toluene can be used.
Palladium oxide, palladium-carbon, or the like can be used. The amount of catalyst added is 10 to 100 g per mol of the protective group.
Is preferred.
反応は水酸基を保護し、任意のアシル基に組み換えたリ
ン脂質誘導体を適当な溶媒に溶解し、触媒を添加後、接
触還元の場合には水素を吹き込み攪拌すればよく、ギ
酸、ギ酸アンモニウム、シクロヘキサジエン等の助触媒
を用いる場合は、この助触媒を基質中の保護基1モルに
つて1〜20当量添加し、不活性ガス気流下で攪拌するこ
とにより得ることができる。この反応は温度−20〜80℃
で行い、好ましくは0〜40℃が良い。10分〜4時間で反
応は終了し、後処理として、反応物をろ過により除き、
ろ液を水でよく洗浄し、乾燥後溶媒を除き、目的とする
任意のアシル基を組み換えたリン脂質を得ることができ
る。The reaction protects the hydroxyl group, dissolves the phospholipid derivative recombined with an arbitrary acyl group in a suitable solvent, and after adding a catalyst, in the case of catalytic reduction, hydrogen may be blown in and stirred, formic acid, ammonium formate, cyclo When a cocatalyst such as hexadiene is used, it can be obtained by adding 1 to 20 equivalents of this cocatalyst to 1 mol of the protective group in the substrate and stirring under an inert gas stream. The temperature of this reaction is -20 to 80 ℃
The temperature is preferably 0 to 40 ° C. The reaction is completed in 10 minutes to 4 hours, and as a post-treatment, the reaction product is removed by filtration.
The filtrate is thoroughly washed with water, and after drying, the solvent is removed to obtain a desired phospholipid in which any desired acyl group is recombined.
保護基に酸触媒により脱離するものを用いた場合には、
溶媒はクロロホルム、ジクロロメタン、ベンゼン、テト
ラヒドロフラン、ジメチルスルホキサイド等の基質をよ
く溶解または分散するものであればよい。酸触媒には、
塩酸、硫酸、硝酸、ホウ酸等の無機酸、および酢酸、p
−トルエンスルホン酸、メタンスルホン酸等の有機酸、
ならびにH+型イオン交換樹脂を用いることができる。酸
触媒の添加量は、分子内の保護基1モルに対し、上記の
酸0.1〜5当量使用すればよく、好ましくは0.5〜2当量
が良い。5分〜数日間の適当な時間を反応時間とするこ
とができ、反応温度は−20〜100℃の間で行うことがで
きるが、基質の安定性を考慮すると0〜40℃で15分〜4
時間の反応が好ましい。反応後水でよく洗浄し、乾燥後
溶媒を除き、目的とする任意のアシル基に組み換えたリ
ン脂質を得ることができる。When a protecting group that is eliminated by an acid catalyst is used,
The solvent may be any solvent that can dissolve or disperse a substrate such as chloroform, dichloromethane, benzene, tetrahydrofuran, dimethyl sulfoxide, etc. Acid catalysts include
Inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, boric acid, and acetic acid, p
-Toluenesulfonic acid, organic acid such as methanesulfonic acid,
And H + type ion exchange resins can be used. The acid catalyst may be added in an amount of 0.1 to 5 equivalents of the above acid, preferably 0.5 to 2 equivalents, relative to 1 mol of the protective group in the molecule. The reaction time can be an appropriate time from 5 minutes to several days, and the reaction temperature can be from −20 to 100 ° C., but considering the stability of the substrate, the reaction time is from 0 to 40 ° C. for 15 minutes to Four
Time reaction is preferred. After the reaction, the product is thoroughly washed with water, dried and then the solvent is removed to obtain a desired phospholipid having a recombinant acyl group.
こうして得られるリン脂質は天然のリン脂質の構造をそ
のまま保持し、アシル基のみが組み換えられた構造であ
るため、組み換えられたアシル基に応じた目的に使用さ
れる。例えばアシル基の鎖長、不飽和度、結合位置を明
らかにする目的の場合には、それらが明らかなリン脂質
として薬理効果の確認等に用いられる。またアシル基に
機能性を持たせる目的の場合、例えばアシル基が生理活
性を有する高度不飽和脂肪酸の場合には、生理活性物質
として用いられ、アシル基が重合性基である場合には、
重合用の単量体として用いられる。さらにこれらのリン
脂質は目的に応じて塩として用いられる。The thus-obtained phospholipid retains the structure of the natural phospholipid as it is and has a structure in which only the acyl group is recombined. Therefore, it is used for the purpose depending on the recombined acyl group. For example, for the purpose of clarifying the chain length, the degree of unsaturation, and the bonding position of an acyl group, they are used as clear phospholipids for confirming the pharmacological effect. For the purpose of imparting functionality to the acyl group, for example, when the acyl group is a polyunsaturated fatty acid having physiological activity, it is used as a physiologically active substance, and when the acyl group is a polymerizable group,
Used as a monomer for polymerization. Further, these phospholipids are used as salts depending on the purpose.
本発明によれば、容易に得られる天然リン脂質混合物を
原料とし、構造の明確なリン脂質を、従来法よりも高い
簡便性、容易性、経済性、純度および収率で製造できる
とともに、従来製造し得なかったリン脂質をも製造でき
る。According to the present invention, a natural phospholipid mixture that is easily obtained can be used as a raw material to produce a phospholipid having a well-defined structure with higher convenience, ease, economy, purity and yield than conventional methods. Phospholipids that could not be produced can also be produced.
以下、実施例および参考例に基づいて本発明を具体的に
説明する。Hereinafter, the present invention will be specifically described based on Examples and Reference Examples.
各例中、%は重量%を示す。また化合物の同定は主とし
て分析法1に示す薄層クロマトグラフィー(TLC)分
析で基準物質との比較で行ったが、必要に応じて分析法
2に示すように質量分析を行った。In each example,% indicates% by weight. Further, the compound was identified mainly by thin layer chromatography (TLC) analysis shown in Analysis Method 1 by comparison with a reference substance, and if necessary, mass spectrometry was performed as shown in Analysis Method 2.
分析法1 TLC分析を以下の要領で行った。Analytical method 1 TLC analysis was performed as follows.
Merck社製NO.5717プレートに20〜100μgの試料を直径3
〜5mmにスポットし、クロロホルム−メタノール−水(6
5:25:4)またはクロロホルム−メタノール−水(120:70:
5)で展開した。展開溶媒を風乾後、検出試薬を噴霧し
た。検出にはDittmer試薬、50%硫酸、ニンヒドリン試
薬、アンスロン試薬を目的に応じて使用した。定量的な
測定には50%硫酸と噴霧し、120℃で20分間加熱して発
色させたものを島津製作所製高速薄層クロマトスキャナ
ーCS-920型で測定した。Merck NO.5717 plate with 20-100 μg of sample
Spot to ~ 5 mm, chloroform-methanol-water (6
5: 25: 4) or chloroform-methanol-water (120: 70:
Deployed in 5). After air-drying the developing solvent, the detection reagent was sprayed. For the detection, Dittmer reagent, 50% sulfuric acid, ninhydrin reagent, and anthrone reagent were used depending on the purpose. For quantitative measurement, 50% sulfuric acid was sprayed and heated at 120 ° C for 20 minutes to develop color, which was measured with a Shimadzu high-speed thin layer chromatography scanner model CS-920.
分析法2 試料を日本電子(株)製JMS-DX303型質分析装置を用
い、下記条件にて分析した。Analysis method 2 The sample was analyzed under the following conditions using a JMS-DX303 type quality analyzer manufactured by JEOL Ltd.
測定条件 イオン化法 :FAB法 衝撃ガス :Xe 一次イオン加速電圧:6kV フィラメント電流 :20mA 検出器 :Conversion Dynode 押し出し電圧 :15kv マトリクス :トリエタノールアミン(陽イオ ンの場合塩化ナトリウム添加) データ処理 :JMA-DA5000 また不純物が多く、そのままでは質量分析にかけられな
い試料については、分析法1と同様にしてTLCで展開
し、該当するスポットの部分を掻く取って抽出したもの
について分析した。Measurement conditions Ionization method: FAB method Impact gas: Xe Primary ion acceleration voltage: 6kV Filament current: 20mA Detector: Conversion Dynode Extrusion voltage: 15kv Matrix: Triethanolamine (sodium chloride added for positive ion) Data processing: JMA- DA5000 Further, with respect to a sample which has a large amount of impurities and cannot be subjected to mass spectrometry as it is, the sample was developed by TLC in the same manner as in the analysis method 1, and the extracted portion by scraping off the corresponding spot was analyzed.
参考例1 酵母から総脂質を抽出し、アセトン分画によりリン脂質
を濃縮した。Reference Example 1 Total lipids were extracted from yeast, and phospholipids were concentrated by acetone fractionation.
市販のパン酵母1kgをクロロホルム−メタノール(1:
1)4、2、1で計3回抽出した。抽出液を集
め、0.2M塩化カリウム水溶液を加えて分層させ、クロ
ロホルム層を減圧乾固し、総脂質16.8gを得た。1 kg of commercially available baker's yeast was mixed with chloroform-methanol (1:
1) Extraction was performed 3 times in total of 4, 2, 1. The extracts were collected, 0.2 M aqueous potassium chloride solution was added to separate the layers, and the chloroform layer was dried under reduced pressure to give 16.8 g of total lipid.
このものを500mlの冷アセトン中に分散して5℃で30分
攪拌し、生じた沈澱を遠心分離して集めた。同じ操作を
200ml、100mlのアセトンを用いて2回繰り返し、得られ
た沈澱2.7gを酵母粗リン脂質とした。This was dispersed in 500 ml of cold acetone, stirred at 5 ° C. for 30 minutes, and the resulting precipitate was collected by centrifugation. Do the same
This was repeated twice with 200 ml and 100 ml of acetone, and 2.7 g of the obtained precipitate was used as a crude yeast phospholipid.
このものの組成は中性脂質28%、ホスファチジルイノシ
トール34%、ホスファチジル酸18%、ホスファチジルコ
リン9%、ホスファチジルエタノールアミン8%であっ
た。Its composition was 28% neutral lipid, 34% phosphatidylinositol, 18% phosphatidyl acid, 9% phosphatidylcholine and 8% phosphatidylethanolamine.
参考例2 牛脳からM.Leesの方法[in"Methods in Enxymology"(S.
P.Colowick and N.O.Kaplaned.),vo1.3,pp328,Achademi
c Press,NewYork(1957)]により粗セファリンを抽出し
た。Reference Example 2 M. Lees' method from cow brain [in "Methods in Enxymology" (S.
P. Colowick and NOKaplaned.), Vo1.3, pp328, Achademi
C Press, New York (1957)] was used to extract crude cephalin.
近在の屠殺場で入手した新鮮な牛脳の脳膜、血管を取り
除いたもの300gを1.2のアセトン中でホモジナイズ
し、抽出した。ろ過残渣をもう一度1.2のアセトンで
抽出し、そのろ過残渣を1.2のエタノールで抽出し
た。さらにそのろ過残渣を同様にして1.2の石油エー
テルで2回抽出し、抽出液を集めた減圧乾固し、粗セフ
ァリン画分3.9gを得た。300 g of fresh bovine brain meninges, devascularized, obtained at a local slaughterhouse were homogenized in 1.2 acetone and extracted. The filtration residue was extracted once again with 1.2 acetone and the filtration residue was extracted with 1.2 ethanol. Further, the filtration residue was extracted twice with 1.2 petroleum ether in the same manner, and the extracts were collected and dried under reduced pressure to obtain 3.9 g of a crude sephaline fraction.
このものの組成はホスファチジルエタノあルアミン31
%、ホスファチジルコリン23%、ホスファチジルイノシ
トール14%、スフィンゴミエリン12%、ホスファチジル
セリン11%、ホスファチジン酸7%であった。The composition of this product is phosphatidyl ethanoalamine 31.
%, Phosphatidylcholine 23%, phosphatidylinositol 14%, sphingomyelin 12%, phosphatidylserine 11%, and phosphatidic acid 7%.
実施例1 市販脱脂大豆レシチン(中性脂質6%、ホスファチジル
コリン26%、ホスファチジルエタノールアミン19%、ホ
スファチジン酸16%、ホスファチジルイノシトール15
%)5gをベンゼン500mlに溶解し、メタンスルホン酸
0.32g,エチルビニルエーテル3.5mlを加えて室温で一夜
攪拌した。反応混液を5%NaHCO3水溶液500mlで洗浄
後、Na2SO4で乾燥し、減圧濃縮した。Example 1 Commercially available defatted soybean lecithin (neutral lipid 6%, phosphatidylcholine 26%, phosphatidylethanolamine 19%, phosphatidic acid 16%, phosphatidylinositol 15)
%) 5 g dissolved in 500 ml benzene, methanesulfonic acid
0.32 g and 3.5 ml of ethyl vinyl ether were added, and the mixture was stirred at room temperature overnight. The reaction mixture was washed with 5% NaHCO 3 aqueous solution (500 ml), dried over Na 2 SO 4 , and concentrated under reduced pressure.
得られた反応物をクロロホルム300mlに溶かし、30℃で
攪拌しつつ1MNaOHメタノール溶液35mlを滴下してアル
カリ加水分解し、脱アシル化した。反応混液にメタノー
ルと水と加え、Folchらの方法[J.Folch,et.al.,J.Biol.
Chem.226,497(1957)]で水洗した。クロロホルム層を取
り、Na2SO4で脱水した後、減圧乾固したものをn−ヘキ
サン約5mlに溶かした。The obtained reaction product was dissolved in 300 ml of chloroform, and 35 ml of a 1M NaOH methanol solution was added dropwise with stirring at 30 ° C. to carry out alkali hydrolysis to deacylate. Methanol and water were added to the reaction mixture, and the method of Folch et al. [J. Folch, et.al., J. Biol.
Chem. 226 , 497 (1957)]. The chloroform layer was removed, dehydrated with Na 2 SO 4 , dried under reduced pressure and dissolved in about 5 ml of n-hexane.
Clarkson Chemicals Co.製Unisilをカラム(径2.2cm、
高さ20cm)に充填し、n−ヘキサンで前処理した。先の
反応物を展着し、n−ヘキサン−クロロホルム(1:
1)150mlでカラムを洗浄後、n−ヘキサンーメタノー
ル(1:9)300mlを流して後半の100mlを集めた。さら
にメタノール150mlを流して後半の100mlを集めた。Unisil column made by Clarkson Chemicals Co. (diameter 2.2 cm,
It was filled to a height of 20 cm) and pretreated with n-hexane. The above reaction product was spread, and n-hexane-chloroform (1:
1) After washing the column with 150 ml, 300 ml of n-hexane-methanol (1: 9) was poured to collect 100 ml of the latter half. Further, 150 ml of methanol was poured to collect 100 ml of the latter half.
n−ヘキサン−メタノール(1:9)溶出画分およびメ
タノール溶出画分をそれぞれNa2SO4で脱水した後、減圧
乾固し、質量分析にかけたところ、n−ヘキサン−メタ
ノール(1:9)溶出画分にはグリセリルホスホリルイ
ノシトールにエトキシエチル基が導入されたと推定され
るものが、メタノール溶出画分にはグリセリルホスホリ
ルエタノールアミンにエトキシエチル基が導入されたと
推定されるものが溶出されていた。The n-hexane-methanol (1: 9) elution fraction and the methanol elution fraction were each dehydrated with Na 2 SO 4 , dried under reduced pressure, and subjected to mass spectrometry to find that n-hexane-methanol (1: 9). It was presumed that the ethoxyethyl group was introduced into glycerylphosphorylinositol in the elution fraction, and the presumed ethoxyethyl group was introduced into glycerylphosphorylethanolamine in the methanol elution fraction.
n−ヘキサン−メタノール(1:9)画分溶出物にジシ
クロヘキシルカルボジイミドを触媒としてジメチルアミ
ノピリジンの存在下にリノール酸を無水物化させて作用
させ、導入した。反応混液を減圧乾固し、クロロホルム
−メタノール−酢酸(4:2:1)に溶かして攪拌し、
適量の水を加えて分層させてクロロホルム層を集め、減
圧乾固した。保護基を離脱させた反応物をTLC分析し
たところ、ホスファチジルイノシトールとRf値が一致す
るスポットが現れ、TLCで分取して質量分析したとこ
ろ、ジリノレイルホスファチジルイノシトールであるこ
とが確認された。To the n-hexane-methanol (1: 9) fraction eluate, linoleic acid was made to act as an anhydride in the presence of dimethylaminopyridine using dicyclohexylcarbodiimide as a catalyst, and introduced. The reaction mixture was evaporated to dryness under reduced pressure, dissolved in chloroform-methanol-acetic acid (4: 2: 1) and stirred,
An appropriate amount of water was added to separate the layers, and the chloroform layer was collected and dried under reduced pressure. TLC analysis of the reaction product from which the protecting group had been removed revealed spots where the Rf values coincided with those of phosphatidylinositol. TLC separation and mass spectrometry confirmed that it was dilinoleylphosphatidylinositol.
メタノール画分溶出物にミリスチン酸クロライドを作用
させ、同様にして保護基を脱離させたものについて分析
したところ、ジミリストイルホスファチジルエタノール
アミンの生成が認められた。シリカゲルカラムクロマト
グラフィーにて精製し、ジミリストイルホスファチジル
エタノールアミン324mgを得た。When the eluate of the methanol fraction was treated with myristic acid chloride and the protective group was eliminated in the same manner, analysis was conducted, and production of dimyristoylphosphatidylethanolamine was observed. Purification by silica gel column chromatography gave 324 mg of dimyristoylphosphatidylethanolamine.
実施例2 参考例1で得た酵母粗リン脂質2.5gをベンゼン−ジメチ
ルスルホキサイド(1:1)250mlに溶解し、窒素気流
下であらかじめ調製した水素化ナトリウム−ジメチルス
ルホキサイドのカルバニオン溶液(水素化ナトリウム1.
2gをジメチルスルホキサイド72ml中で窒素圧流下に65〜
70℃で攪拌して得られた暗緑色の溶液)62.5mlを攪拌し
つつ滴下した。3時間攪拌後、氷冷下に塩化ベンジル20
mlを滴下し、さらに6時間攪拌した。ベンゼン450mlで
抽出し、1の水で3回洗浄後減圧濃縮した。Example 2 2.5 g of yeast crude phospholipid obtained in Reference Example 1 was dissolved in 250 ml of benzene-dimethyl sulfoxide (1: 1), and a carbanion solution of sodium hydride-dimethyl sulfoxide was prepared in advance under a nitrogen stream. (Sodium hydride 1.
65 g of 2 g in 72 ml of dimethyl sulfoxide under nitrogen pressure flow.
62.5 ml of a dark green solution obtained by stirring at 70 ° C. was added dropwise with stirring. After stirring for 3 hours, cool with benzyl chloride 20
ml was added dropwise, and the mixture was further stirred for 6 hours. It was extracted with 450 ml of benzene, washed 3 times with water of 1 and concentrated under reduced pressure.
実施例1と同様にして脱アシル化し、水洗した。クロロ
ホルム層を乾燥し、減圧乾固したものを3mlのベンゼン
に溶かした。It was deacylated and washed with water in the same manner as in Example 1. The chloroform layer was dried, dried under reduced pressure, and dissolved in 3 ml of benzene.
Merck社製Silica Gel 60を充填し、イソオクタン−ベン
ゼン(9:1)で前処理したカラム(径2cm、高さ18c
m)に上記試験料を展着した。カラムをイソオクタン−
アセトン(3:2)200mlで洗浄後、イソオクタン−ア
セトン(2:8)200mlで溶出した。イソオクタンーア
セトン(2:8)画分を濃縮し、グリセリルホスホリル
イノシトールベンジル化物205mgを得た。Column packed with Merck Silica Gel 60 and pretreated with isooctane-benzene (9: 1) (diameter 2 cm, height 18 c
The test fee was spread to m). Column is isooctane
After washing with 200 ml of acetone (3: 2), it was eluted with 200 ml of isooctane-acetone (2: 8). The isooctane-acetone (2: 8) fraction was concentrated to obtain 205 mg of glyceryl phosphoryl inositol benzyl compound.
これをジクロロメタン200mlに溶解し、ピリジン0.1ml、
2%ミリスチン酸塩化物クロロホルム溶液20mlを加え、
室温で5時間攪拌後200mlの水で3回洗浄し、減圧濃縮
した。クロロホルム−メタノール−水(65:25:4)で前処
理したシリカゲルカラム(径1.5cm、高さ20cm)にクロ
ロホルム10mlに溶かした反応物を展着し、同じ溶媒で溶
出して未反応物を除去した。目的反応物を含む画分を集
めて減圧乾固した。This is dissolved in 200 ml of dichloromethane and 0.1 ml of pyridine,
Add 20 ml of 2% myristate chloride chloroform solution,
The mixture was stirred at room temperature for 5 hours, washed with 200 ml of water three times, and concentrated under reduced pressure. The reaction product dissolved in 10 ml of chloroform was spread on a silica gel column (diameter 1.5 cm, height 20 cm) pretreated with chloroform-methanol-water (65: 25: 4) and eluted with the same solvent to remove unreacted products. Removed. Fractions containing the desired reaction product were collected and dried under reduced pressure.
このものをベンゼン200mlに溶解し、0.63gの10%パラジ
ウム−チャコールを加えて水素気流下にて42℃で攪拌し
た。パラジウム−チャコールをろ別し、減圧濃縮したも
のをクロロホルム10mlに溶かした。クロロホルムーメタ
ノール−水(65:25:4)で前処理されたシリカゲルカラム
(径1.5cm、高さ20cm)に展着し、同じ溶媒で溶出して
酵母標準ホスファチジルイノシトールとTLC上でRf値
のほぼ一致するスポットを与える目的反応物の溶出した
画分を集めて減圧乾固し、固形物219mgを得た。This was dissolved in 200 ml of benzene, 0.63 g of 10% palladium-charcoal was added, and the mixture was stirred at 42 ° C under a hydrogen stream. Palladium-charcoal was separated by filtration, concentrated under reduced pressure, and dissolved in 10 ml of chloroform. Chloroform-methanol-water (65: 25: 4) pre-treated silica gel column (diameter 1.5 cm, height 20 cm) was spread and eluted with the same solvent as yeast standard phosphatidylinositol and Rf value on TLC. Fractions from which the desired reaction product giving almost identical spots were eluted and dried under reduced pressure to obtain 219 mg of a solid substance.
このものがジミリストイルホスファチジルイノシトール
であることを質量分析で確認した。It was confirmed by mass spectrometry that this was dimyristoylphosphatidylinositol.
実施例3 参考例2で得た牛脳粗セファリン画分3.9gをクロロホル
ム380mlに溶解し、p−トルエンスルホン酸1g、イソ
プロピルケトン4.5mlを加え、353時間攪拌した。実施
例1と同様にして洗浄し、一旦減圧濃縮したものをクロ
ロホルム溶液として脱アシル化した。Example 3 3.9 g of the crude bovine brain cephalin fraction obtained in Reference Example 2 was dissolved in 380 ml of chloroform, 1 g of p-toluenesulfonic acid and 4.5 ml of isopropyl ketone were added, and the mixture was stirred for 353 hours. The product was washed in the same manner as in Example 1, and once concentrated under reduced pressure, it was deacylated as a chloroform solution.
クロロホルムで前処理した(株)ヤトロン製イアトロビ
ーズ6RS-80100カラム(径2.2cm、高さ33cm)に試料を展
着し、クロロホルム−メノルール(2:1)240mlにて
カラムを洗浄後、クロロホルム−メタノール(3:2)
130ml,クロロホルム−メタノール(3:7)200mlおよ
びクロロホルム−メタノール−水(65:25:4)300mlで順次
溶出した。The sample was spread on a Jatro Inatiabeads 6RS-80100 column (diameter 2.2 cm, height 33 cm) pretreated with chloroform, and the column was washed with 240 ml of chloroform-menolol (2: 1), followed by chloroform-methanol. (3: 2)
130 ml, chloroform-methanol (3: 7) 200 ml, and chloroform-methanol-water (65: 25: 4) 300 ml were sequentially eluted.
クロロホルム−メタノール(3:2)画分にはグリセリ
ルホスホリルイノシトールにイソプロピリデン基が導入
されたものが、クロロホルム−メタノール(3:7)画
分にはグリセリルホスホリルセリンにイソプロピリデン
基が導入されたものが、クロロホルム−メタノール−水
(65:25:4)画分にはグリセリルホスホリルエタノールア
ミンにイソプロピリデン基が導入されたものがそれぞれ
溶出されていた。Chloroform-methanol (3: 2) fraction with isopropylidene group introduced into glycerylphosphorylinositol, chloroform-methanol (3: 7) fraction with isopropylidene group introduced into glycerylphosphorylserine But chloroform-methanol-water
In the (65: 25: 4) fraction, glycerylphosphorylethanolamine with isopropylidene group introduced was eluted.
クロロホルム−メタノール(3:2)溶出画分にはカプ
リル酸を、クロロホルム−メタノール(3:7)溶出画
分にはイソステアリン酸をそれぞれ脂肪酸塩化物として
作用させ、クロロホルム−メタノール−水(65:25:4)溶
出画分にはアラキドン酸を酸無水物として作用させ導入
した。Chloroform-methanol-water (65:25) was used to cause caprylic acid to act in the chloroform-methanol (3: 2) elution fraction and isostearic acid to act in the chloroform-methanol (3: 7) elution fraction, respectively. : 4) Arachidonic acid was introduced as the acid anhydride into the eluted fraction.
それぞれイソプロピリデン基を脱離させ、シリカゲルカ
ラムクロマトグラフィーにて精製して、ジオクタノイル
ホスファチジルイノシトール97mg、ジイソステアロイル
ホスファジルエタノールアミン353mg、ジアラキドイル
ホスファチジルセリン112mgを得た。The isopropylidene group was eliminated and the product was purified by silica gel column chromatography to obtain 97 mg of dioctanoylphosphatidylinositol, 353 mg of diisostearoylphosphatidylethanolamine, and 112 mg of diarachidoylphosphatidylserine.
実施例4 市販卵黄レシチン(ホスファチジルコリン64%、ホスフ
ァチジルエタノールアミン19%、ホスファチジン酸7
%、スフィンゴミエリン5%、リゾホスファチジルコリ
ン3%)10gを四塩化炭素500mlに溶解し、p−トルエン
スルホン酸0.75gおよび3,4-ジヒドロ−α−ピラン5.2g
を加え、室温で4時間攪拌した。実施例1と同様にして
洗浄後減圧濃縮し、クロロホルム中でアルカリ加水分解
により脱アシル化した。アルカリを蟻酸エチルで中和
し、そのまま減圧乾固したものをジイソプロピルエーテ
ル50mlに溶かし、試料を調製した。Example 4 Commercial egg yolk lecithin (phosphatidylcholine 64%, phosphatidylethanolamine 19%, phosphatidic acid 7)
%, Sphingomyelin 5%, lysophosphatidylcholine 3%) 10 g were dissolved in carbon tetrachloride 500 ml, and p-toluenesulfonic acid 0.75 g and 3,4-dihydro-α-pyran 5.2 g
Was added, and the mixture was stirred at room temperature for 4 hours. After washing in the same manner as in Example 1, the solution was concentrated under reduced pressure and deacylated by alkaline hydrolysis in chloroform. The alkali was neutralized with ethyl formate, dried under reduced pressure to dissolve it in 50 ml of diisopropyl ether, and a sample was prepared.
ジイソプロピルエーテル−アセトニトリル(8:2)で
前処理した和光純薬工業(株)製ワコーゲルC300を200
g充填したカラムに上記試料を加え、バッチ式で処理し
た。ゲルを同じ溶媒2で3回洗浄した後、ジイソプロ
ピルエーテル−アセトニトリル(2:8)2で3回抽
出し、さらに10%含水メタノール2で5回抽出した。200 Wako Gel C300 manufactured by Wako Pure Chemical Industries, Ltd. pretreated with diisopropyl ether-acetonitrile (8: 2)
g The above sample was added to a packed column and processed in batch mode. The gel was washed 3 times with the same solvent 2, then extracted 3 times with diisopropyl ether-acetonitrile (2: 8) 2 and 5 times with 10% hydrous methanol 2.
TLC分析したところ、ジイソプロピルエーテル−アセ
トニトリル(2:8)画分にはグリセリルホスホリルエ
タノールアミンにテトラヒドロピラニル基が導入された
ものが、10%含水メタノール画分にはグリセリルホスホ
リルコリンが、それぞれ溶出されていた。TLC analysis revealed that the diisopropyl ether-acetonitrile (2: 8) fraction was eluted with a tetrahydropyranyl group introduced into glycerylphosphorylethanolamine, and the 10% hydrous methanol fraction was eluted with glycerylphosphorylcholine. It was
ジイソプロピルエーテル−アセトニトリル(2:8)溶
出画分にフィタン酸を脂肪酸塩化物として作用させて導
入し、テトラヒドロピラニル基を脱離させ、カラムクロ
マトグラフィーにて精製し、ジフィタノイルホスファチ
ジルエタノールアミン1.08gを得た。Phytanic acid was introduced as a fatty acid chloride into the elution fraction of diisopropyl ether-acetonitrile (2: 8) to remove the tetrahydropyranyl group and purified by column chromatography to obtain diphytanoylphosphatidylethanolamine 1.08. got g.
10%含水メタノール溶出画分にはパルミチン酸を脂肪酸
塩化物として作用させて導入し、カラムクロマトグラフ
ィーにて精製してジパルミトイルホスファチジルコリン
4.15gを得た。Palmitic acid was introduced as a fatty acid chloride into the 10% hydrous methanol elution fraction, and purified by column chromatography to obtain dipalmitoylphosphatidylcholine.
4.15 g was obtained.
Claims (6)
脱アシル化して下記式(I) (式中、Xは含窒素アルコール残基またはポリオール残
基を、Yは容易に着脱可能な保護基を、nは12以下の自
然数を示す。) で示されるグリセリルリン酸エステル誘導体に変換し、
ケイ酸を分離剤として分離精製した後、任意のアシル基
を導入して保護基を脱離させることを特徴とするリン脂
質の製造方法。1. A crude phospholipid having a removable protective group introduced therein,
Following deacylation, the following formula (I) (In the formula, X represents a nitrogen-containing alcohol residue or a polyol residue, Y represents an easily removable protecting group, and n represents a natural number of 12 or less.), And a glyceryl phosphate derivative represented by
A method for producing a phospholipid, which comprises separating and purifying silicic acid as a separating agent, and then introducing an arbitrary acyl group to eliminate the protecting group.
メチルエタノールアミン基、N,N-ジメチルエタノールア
ミン基、N,N,N-トリメチルエタノールアミン基、グリセ
ロール基、アミノアシルグリセロール基、グリセロリン
酸基、グリセリルホスファチジル基、イノシトール基、
イノシトールリン酸基、イノシトールジリン酸基、単
糖、二糖およびオリゴ糖から選ばれる少なくとも1種類
からなるものである特許請求の範囲第1項記載の製造方
法。2. X is serine group, ethanolamine group, N-
Methylethanolamine group, N, N-dimethylethanolamine group, N, N, N-trimethylethanolamine group, glycerol group, aminoacylglycerol group, glycerophosphate group, glycerylphosphatidyl group, inositol group,
The production method according to claim 1, which comprises at least one selected from an inositol phosphate group, an inositol diphosphate group, a monosaccharide, a disaccharide and an oligosaccharide.
ル基、アルキロイル基、アルケニル基、アルケロイル基
またはアリール基である特許請求の範囲第1項または第
2項記載の製造方法。3. The method according to claim 1 or 2, wherein Y is a linear, branched or cyclic alkyl group, an alkyloyl group, an alkenyl group, an alkeroyl group or an aryl group.
状、分岐鎖状もしくは環状の飽和または不飽和脂肪酸で
ある特許請求の範囲第1項ないし第3項のいずれかに記
載の製造方法。4. The production according to any one of claims 1 to 3, wherein the acyl group to be introduced is a linear, branched or cyclic saturated or unsaturated fatty acid having 30 or less carbon atoms. Method.
m、細孔径0.25〜10μmである特許請求の範囲第1項な
いし第4項のいずれかに記載の製造方法。5. Silicic acid as a separating agent has a particle size of 10 to 800 μm.
The manufacturing method according to any one of claims 1 to 4, wherein m and pore diameter are 0.25 to 10 µm.
酸エステル誘導体を分離剤に吸着させ、分離剤を洗浄
後、極性の高い溶媒でグリセリルリン酸エステル誘導体
を溶離する特許請求の範囲第1項ないし第5項のいずれ
かに記載の製造方法。6. A glyceryl phosphate derivative is adsorbed on a separating agent in the presence of a solvent of low polarity, the separating agent is washed, and then the glyceryl phosphate derivative is eluted with a solvent of high polarity. Item 6. The manufacturing method according to any one of Items 5 to 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62015782A JPH0613538B2 (en) | 1987-01-26 | 1987-01-26 | Method for producing phospholipid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62015782A JPH0613538B2 (en) | 1987-01-26 | 1987-01-26 | Method for producing phospholipid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63185990A JPS63185990A (en) | 1988-08-01 |
| JPH0613538B2 true JPH0613538B2 (en) | 1994-02-23 |
Family
ID=11898390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62015782A Expired - Lifetime JPH0613538B2 (en) | 1987-01-26 | 1987-01-26 | Method for producing phospholipid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0613538B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116396800B (en) * | 2023-05-04 | 2023-12-19 | 浙江得乐康食品股份有限公司 | Method for degumming rice bran oil by combining mixed solvent, citric acid and alkali |
-
1987
- 1987-01-26 JP JP62015782A patent/JPH0613538B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63185990A (en) | 1988-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880001232B1 (en) | Process for the preparation of new ganglioside derivatives | |
| EP0922707B2 (en) | A process for the purification of phosphatidylserine | |
| JPH09505071A (en) | Glucosamine disaccharides, processes for their production, pharmaceutical compositions containing them and their use | |
| EP0143840A1 (en) | MONOSACCHARIDE COMPOUNDS WITH IMMUNOSTIMULATORY ACTIVITY. | |
| HU193151B (en) | Process for producing ganglyoside derivatives and pharmaceutical compositions containing them as active agents | |
| EP0373038A2 (en) | New lysosphingolipid derivatives | |
| EP0080442B1 (en) | Process for the preparation of di-galactose derivatives | |
| Qureshi et al. | Application of fast atom bombardment mass spectrometry and nuclear magnetic resonance on the structural analysis of purified lipid A | |
| Datta et al. | An improved synthesis of trehalose 6-mono and 6, 6′-dicorynomycolates and related esters | |
| Charon et al. | Chemical synthesis and immunological activities of glycolipids structurally related to lipid A | |
| JPH0613538B2 (en) | Method for producing phospholipid | |
| US4725588A (en) | Alkyl phospholipid antihypertensive agents in method of lowering blood pressure | |
| Hasegawa et al. | Synthetic Studies on Sialoglycoconjugates 14: Synthesis of Ganglioside GM3 Analogs Containing The Carbon 7 And 8 Sialic Acids | |
| EP0373039A2 (en) | New lysoganglioside derivatives | |
| GB2058792A (en) | Process for the Preparation of L- alpha -Glycerylphosphoryl Choline | |
| Inagaki et al. | Isolation and structure of a new ganglioside molecular species | |
| Lazar et al. | A selective removal of benzyl protecting groups in arylphosphate esters with bromotrimethylsilane | |
| US4690784A (en) | Process for preparing phosphatidylcholine derivatives | |
| JPS6333386A (en) | Method for separating and purifying glycerylphosphoric ester compound derivative | |
| JP4913272B2 (en) | Method for producing oligosaccharide, novel oligosaccharide and pharmaceutical composition containing the same | |
| US5472951A (en) | Stabilizer for phospholipid vesicles | |
| CA1266642A (en) | Monosaccharide compounds having immunostimulating activity | |
| EP0540790B1 (en) | Method of obtaining monosialogangliosides | |
| Kusumoto et al. | Chemical synthesis of bacterial lipid A | |
| Kamio et al. | Galactosylceramide containing omega-amino-fatty acids: preparation, characterization, and sulfotransferase acceptor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |